Index -
P/E 2.14
EPS (ttm) 5.21
Insider Own 31.57%
Shs Outstand 760.14M
Perf Week -2.28%
Market Cap 8.97B
Forward P/E -
EPS next Y -1.18
Insider Trans -1.20%
Shs Float 551.48M
Perf Month -0.36%
Income 4.47B
PEG -
EPS next Q -0.28
Inst Own 53.85%
Short Float 8.26%
Perf Quarter 2.96%
Sales 123.24M
P/S 72.78
EPS this Y 550.87%
Inst Trans 2.60%
Short Ratio 6.56
Perf Half Y 23.94%
Book/sh 7.57
P/B 1.47
EPS next Y -122.64%
ROA 91.47%
Short Interest 45.58M
Perf Year 20.59%
Cash/sh 8.28
P/C 1.34
EPS next 5Y -
ROE 123.54%
52W Range 8.24 - 13.24
Perf YTD -0.89%
Dividend Est. -
P/FCF -
EPS past 5Y 21.79%
ROI 68.29%
52W High -15.94%
Beta 1.29
Dividend TTM -
Quick Ratio 27.77
Sales past 5Y 571.16%
Gross Margin 72.86%
52W Low 34.99%
ATR (14) 0.33
Dividend Ex-Date -
Current Ratio 27.79
EPS Y/Y TTM 411.84%
Oper. Margin -850.46%
RSI (14) 51.79
Volatility 2.58% 2.75%
Employees 904
Debt/Eq 0.08
Sales Y/Y TTM 185.76%
Profit Margin 3624.14%
Recom 1.17
Target Price 16.08
Option/Short Yes / Yes
LT Debt/Eq 0.07
EPS Q/Q 1322.86%
Payout -
Rel Volume 0.37
Prev Close 11.25
Sales Surprise 16.89%
EPS Surprise 2051.46%
Sales Q/Q 117.80%
Earnings Feb 13 BMO
Avg Volume 6.94M
Price 11.13
SMA20 1.45%
SMA50 2.30%
SMA200 4.64%
Trades
Volume 2,563,948
Change -1.07%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-15-24 Initiated
Wolfe Research
Outperform
$17
Jan-05-24 Initiated
Piper Sandler
Overweight
$20
Dec-12-23 Initiated
Deutsche Bank
Buy
$14
Oct-17-23 Initiated
Guggenheim
Buy
$17
Jun-08-23 Initiated
BofA Securities
Neutral
$10.50
Oct-27-22 Initiated
JP Morgan
Overweight
$7
May-23-22 Initiated
SVB Leerink
Outperform
$6
Apr-29-22 Initiated
Cantor Fitzgerald
Overweight
$15
Dec-15-21 Initiated
Goldman
Buy
$15
Nov-08-21 Initiated
H.C. Wainwright
Buy
$14
Oct-28-21 Initiated
Citigroup
Buy
$11
Oct-26-21 Initiated
Truist
Buy
$15
Oct-26-21 Initiated
Jefferies
Buy
$10
Oct-26-21 Initiated
Cowen
Outperform
Show Previous Ratings
May-08-24 02:43AM
May-07-24 02:04PM
May-01-24 10:47AM
Apr-25-24 08:00AM
Apr-12-24 11:09AM
07:00AM
Loading…
Apr-02-24 07:00AM
Mar-27-24 01:55PM
(The Wall Street Journal) +7.54%
Mar-26-24 06:22PM
Mar-17-24 08:50AM
Mar-14-24 07:04AM
Feb-15-24 02:45AM
Feb-13-24 07:00AM
Feb-10-24 02:55AM
Jan-30-24 04:05PM
Dec-27-23 08:05PM
04:30PM
Loading…
Dec-20-23 04:30PM
Dec-14-23 09:00AM
Nov-28-23 07:00AM
02:38AM
Nov-27-23 08:00AM
Nov-14-23 01:00PM
Nov-13-23 07:00AM
Nov-10-23 08:00AM
Oct-30-23 05:30PM
Oct-24-23 08:00AM
(The Wall Street Journal)
Oct-23-23 03:02PM
10:31AM
09:52AM
06:55AM
(The Wall Street Journal)
03:49AM
(The Wall Street Journal)
01:00AM
Loading…
01:00AM
Oct-13-23 08:00AM
Oct-05-23 05:01AM
Oct-03-23 07:00AM
(The Wall Street Journal)
Sep-30-23 05:00AM
Sep-26-23 06:00AM
Sep-11-23 08:00AM
Sep-09-23 10:51AM
(The Wall Street Journal)
Aug-17-23 04:05PM
Aug-14-23 07:00AM
Aug-03-23 04:05PM
Aug-02-23 04:05PM
Jul-27-23 08:00AM
Jul-26-23 10:21AM
Jul-13-23 05:50PM
(The Wall Street Journal)
Jul-11-23 08:00AM
Jun-28-23 08:57AM
07:00AM
Jun-26-23 04:05PM
Jun-22-23 07:30AM
Jun-21-23 05:00PM
May-16-23 07:00AM
Apr-04-23 07:37AM
07:37AM
Mar-28-23 08:00AM
Mar-15-23 07:45AM
Mar-14-23 04:07PM
08:00AM
Mar-07-23 08:00AM
Feb-21-23 08:32PM
Feb-13-23 04:17PM
(The Wall Street Journal)
07:00AM
Feb-02-23 09:14PM
Feb-01-23 04:05PM
Jan-30-23 08:00AM
Jan-04-23 06:05AM
Dec-07-22 06:30AM
Dec-01-22 08:00AM
Nov-14-22 07:00AM
Nov-10-22 09:00AM
Nov-08-22 06:15AM
Nov-07-22 04:01PM
Oct-18-22 04:00PM
Aug-30-22 07:00AM
Aug-16-22 11:44AM
Aug-15-22 07:00AM
Aug-14-22 10:53AM
Aug-03-22 07:00AM
Jul-23-22 09:00AM
Jun-30-22 09:18AM
Jun-28-22 06:27AM
06:10AM
06:00AM
Jun-15-22 04:30PM
May-24-22 06:00AM
May-19-22 04:30PM
May-16-22 07:00AM
May-09-22 11:16AM
(Simply Wall St.) -12.71%
May-02-22 07:00AM
Apr-20-22 07:00AM
Apr-13-22 07:00AM
Mar-25-22 08:01AM
Mar-24-22 07:00AM
Mar-11-22 04:45PM
Mar-07-22 11:18AM
Feb-28-22 06:01AM
Feb-14-22 07:00AM
Feb-07-22 07:00AM
Jan-25-22 04:30PM
Jan-05-22 04:30PM
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Venker Eric President & COO Feb 09 '24 Option Exercise 3.85 96,950 373,258 629,157 Feb 09 09:00 PM Venker Eric President & COO Feb 09 '24 Sale 10.92 96,950 1,058,694 532,207 Feb 09 09:00 PM Ramaswamy Vivek 10% Owner Jan 02 '24 Sale 11.05 3,000,000 33,150,000 51,929,426 Jan 03 04:56 PM Venker Eric Chief Operating Officer Oct 05 '23 Sale 10.11 153,027 1,547,103 595,397 Oct 04 09:30 PM Venker Eric Chief Operating Officer Oct 04 '23 Option Exercise 3.85 153,027 589,154 748,424 Oct 04 09:30 PM Venker Eric Chief Operating Officer Oct 03 '23 Option Exercise 3.85 606,221 2,333,951 1,201,618 Oct 04 09:30 PM Venker Eric Chief Operating Officer Oct 03 '23 Sale 10.25 606,221 6,213,765 595,397 Oct 04 09:30 PM Venker Eric Chief Operating Officer Oct 02 '23 Option Exercise 3.85 440,752 1,696,895 1,036,149 Oct 04 09:30 PM Roivant Sciences Ltd. Director Oct 02 '23 Buy 38.00 1,526,316 58,000,008 79,805,331 Oct 04 05:15 PM Venker Eric Chief Operating Officer Oct 02 '23 Sale 10.80 440,752 4,760,122 595,397 Oct 04 09:30 PM SVF Investments (UK) Ltd 10% Owner Sep 28 '23 Sale 12.60 10,000,000 126,000,000 73,031,667 Oct 02 09:00 PM Gold Daniel Allen Director Sep 28 '23 Sale 11.55 10,000,000 115,500,000 100,804 Oct 02 08:55 PM QVT Financial LP Director by Deputization Sep 28 '23 Sale 11.55 10,000,000 115,500,000 100,804 Oct 02 08:43 PM MANCHESTER KEITH S Director Sep 28 '23 Sale 11.55 6,896,144 79,650,463 5,023,787 Oct 02 09:05 PM Venker Eric President & COO Sep 27 '23 Option Exercise 3.85 500,000 1,925,000 1,095,397 Sep 29 09:30 PM Venker Eric President & COO Sep 27 '23 Sale 13.02 500,000 6,510,000 595,397 Sep 29 09:30 PM Kumar Rakhi Chief Accounting Officer Sep 08 '23 Option Exercise 6.48 99,350 643,788 297,300 Sep 12 09:30 PM Venker Eric Chief Operating Officer Sep 08 '23 Option Exercise 3.85 106,430 409,756 718,243 Sep 12 09:32 PM Venker Eric Chief Operating Officer Sep 08 '23 Sale 12.19 106,430 1,297,382 611,813 Sep 12 09:32 PM Kumar Rakhi Chief Accounting Officer Sep 08 '23 Sale 12.18 99,350 1,210,083 197,950 Sep 12 09:30 PM Venker Eric Chief Operating Officer Sep 06 '23 Option Exercise 3.85 5,926 22,815 617,739 Sep 06 09:30 PM Venker Eric Chief Operating Officer Sep 06 '23 Sale 11.85 5,926 70,223 611,813 Sep 06 09:30 PM Venker Eric Chief Operating Officer Sep 05 '23 Option Exercise 3.85 73,275 282,109 685,088 Sep 06 09:30 PM Kumar Rakhi Chief Accounting Officer Sep 05 '23 Option Exercise 6.48 1,724 11,172 199,674 Sep 07 09:30 PM Venker Eric Chief Operating Officer Sep 05 '23 Sale 11.92 73,275 873,438 611,813 Sep 06 09:30 PM Kumar Rakhi Chief Accounting Officer Sep 05 '23 Sale 12.00 1,724 20,688 197,950 Sep 07 09:30 PM Venker Eric Chief Operating Officer Sep 01 '23 Option Exercise 3.85 14,763 56,838 626,576 Sep 06 09:30 PM Venker Eric Chief Operating Officer Sep 01 '23 Sale 11.90 14,763 175,680 611,813 Sep 06 09:30 PM Venker Eric Chief Operating Officer Aug 14 '23 Option Exercise 3.85 59,811 230,272 687,729 Aug 16 09:34 PM Venker Eric Chief Operating Officer Aug 14 '23 Sale 11.89 59,811 711,153 627,918 Aug 16 09:34 PM Venker Eric Chief Operating Officer Aug 03 '23 Option Exercise 3.85 44,629 171,822 672,547 Aug 07 09:30 PM Kumar Rakhi Chief Accounting Officer Aug 03 '23 Option Exercise 6.48 3,681 23,853 203,009 Aug 03 09:30 PM Venker Eric Chief Operating Officer Aug 03 '23 Sale 11.93 44,629 532,424 627,918 Aug 07 09:30 PM Kumar Rakhi Chief Accounting Officer Aug 03 '23 Sale 12.00 3,681 44,172 199,328 Aug 03 09:30 PM Venker Eric Chief Operating Officer Aug 02 '23 Option Exercise 3.85 16,397 63,128 644,315 Aug 02 09:30 PM Venker Eric Chief Operating Officer Aug 02 '23 Sale 11.86 16,397 194,468 627,918 Aug 02 09:30 PM Venker Eric Chief Operating Officer Aug 01 '23 Option Exercise 3.85 61,397 236,378 689,315 Aug 02 09:30 PM Kumar Rakhi Chief Accounting Officer Aug 01 '23 Option Exercise 6.48 336 2,177 199,664 Aug 03 09:30 PM Venker Eric Chief Operating Officer Aug 01 '23 Sale 11.92 61,397 731,852 627,918 Aug 02 09:30 PM Kumar Rakhi Chief Accounting Officer Aug 01 '23 Sale 12.00 336 4,032 199,328 Aug 03 09:30 PM Venker Eric Chief Operating Officer Jul 31 '23 Option Exercise 3.85 117,372 451,882 745,290 Aug 02 09:30 PM Venker Eric Chief Operating Officer Jul 31 '23 Sale 11.91 117,372 1,397,901 627,918 Aug 02 09:30 PM Venker Eric Chief Operating Officer Jul 27 '23 Option Exercise 3.85 23,622 90,945 651,540 Jul 27 09:30 PM Venker Eric Chief Operating Officer Jul 27 '23 Sale 10.98 23,622 259,370 627,918 Jul 27 09:30 PM Venker Eric Chief Operating Officer Jul 26 '23 Option Exercise 3.85 73,568 283,237 701,486 Jul 27 09:30 PM Venker Eric Chief Operating Officer Jul 26 '23 Sale 10.91 73,568 802,627 627,918 Jul 27 09:30 PM Venker Eric Chief Operating Officer Jul 25 '23 Option Exercise 3.85 28,344 109,124 656,262 Jul 27 09:30 PM Venker Eric Chief Operating Officer Jul 25 '23 Sale 10.86 28,344 307,816 627,918 Jul 27 09:30 PM Venker Eric President & COO Jul 24 '23 Option Exercise 3.85 33,081 127,362 677,296 Jul 24 09:31 PM Venker Eric President & COO Jul 24 '23 Sale 10.93 33,081 361,575 644,215 Jul 24 09:31 PM Venker Eric President & COO Jul 21 '23 Option Exercise 3.85 181,998 700,692 826,213 Jul 24 09:31 PM Venker Eric President & COO Jul 21 '23 Sale 11.13 181,998 2,025,638 644,215 Jul 24 09:31 PM Venker Eric President & COO Jul 20 '23 Option Exercise 3.85 159,387 613,640 803,602 Jul 24 09:31 PM Venker Eric President & COO Jul 20 '23 Sale 11.31 159,387 1,802,667 644,215 Jul 24 09:31 PM Kumar Rakhi Chief Accounting Officer Jul 18 '23 Option Exercise 6.48 100 648 82,228 Jul 18 09:30 PM Kumar Rakhi Chief Accounting Officer Jul 18 '23 Sale 12.00 100 1,200 82,128 Jul 18 09:30 PM Kumar Rakhi Chief Accounting Officer Jul 14 '23 Option Exercise 6.48 535 3,467 82,663 Jul 18 09:30 PM Kumar Rakhi Chief Accounting Officer Jul 14 '23 Sale 12.00 535 6,420 82,128 Jul 18 09:30 PM Sumitomo Chemical Co., Ltd. 10% Owner Jun 22 '23 Sale 8.60 15,116,277 129,999,982 71,251,083 Jun 26 04:05 PM VIKING GLOBAL PERFORMANCE LLC 10% Owner Jun 22 '23 Sale 9.90 13,000,000 128,700,000 641,010 Jun 26 05:10 PM VIKING GLOBAL INVESTORS LP 10% Owner Jun 22 '23 Sale 9.90 13,000,000 128,700,000 641,010 Jun 26 05:11 PM Venker Eric President & COO Jun 09 '23 Option Exercise 3.85 299,384 1,152,628 959,481 Jun 09 09:32 PM Kumar Rakhi Chief Accounting Officer Jun 09 '23 Option Exercise 5.12 43,893 224,732 242,475 Jun 13 09:31 PM Venker Eric President & COO Jun 09 '23 Sale 9.91 299,384 2,966,895 660,097 Jun 09 09:32 PM Kumar Rakhi Chief Accounting Officer Jun 09 '23 Sale 9.93 43,893 435,857 198,582 Jun 13 09:31 PM Venker Eric President & COO Jun 07 '23 Option Exercise 3.85 201 774 660,298 Jun 09 09:32 PM Venker Eric President & COO Jun 07 '23 Sale 9.85 201 1,980 660,097 Jun 09 09:32 PM Venker Eric President & COO May 23 '23 Option Exercise 3.85 415 1,598 676,183 May 25 09:30 PM Venker Eric President & COO May 23 '23 Sale 9.85 415 4,088 675,768 May 25 09:30 PM
Index -
P/E -
EPS (ttm) -0.15
Insider Own 24.77%
Shs Outstand 178.08M
Perf Week 4.67%
Market Cap 2.67B
Forward P/E 43.21
EPS next Y 0.37
Insider Trans 0.00%
Shs Float 124.37M
Perf Month -6.76%
Income 3.35M
PEG -
EPS next Q -0.04
Inst Own 58.87%
Short Float 22.90%
Perf Quarter -3.01%
Sales 206.43M
P/S 12.92
EPS this Y -99.63%
Inst Trans -1.88%
Short Ratio 7.22
Perf Half Y 2.94%
Book/sh 6.88
P/B 2.34
EPS next Y 26025.47%
ROA 0.14%
Short Interest 28.48M
Perf Year -28.57%
Cash/sh 5.73
P/C 2.81
EPS next 5Y 32.30%
ROE 0.27%
52W Range 12.68 - 26.53
Perf YTD -18.74%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI 0.16%
52W High -39.20%
Beta 2.30
Dividend TTM -
Quick Ratio 9.28
Sales past 5Y 51.37%
Gross Margin 17.73%
52W Low 27.21%
ATR (14) 0.75
Dividend Ex-Date -
Current Ratio 10.29
EPS Y/Y TTM -98.49%
Oper. Margin -31.83%
RSI (14) 52.37
Volatility 3.70% 4.31%
Employees 681
Debt/Eq 0.83
Sales Y/Y TTM -54.82%
Profit Margin 1.62%
Recom 1.70
Target Price 21.22
Option/Short Yes / Yes
LT Debt/Eq 0.83
EPS Q/Q -141.68%
Payout 0.00%
Rel Volume 1.00
Prev Close 16.32
Sales Surprise 3.01%
EPS Surprise -18.34%
Sales Q/Q -49.13%
Earnings May 02 AMC
Avg Volume 3.95M
Price 16.13
SMA20 -0.09%
SMA50 5.15%
SMA200 -8.09%
Trades
Volume 3,927,360
Change -1.16%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-23-24 Downgrade
JP Morgan
Overweight → Neutral
$20 → $16
Mar-13-24 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$26 → $15.50
Sep-06-23 Upgrade
Northland Capital
Market Perform → Outperform
Aug-31-23 Initiated
JP Morgan
Overweight
$27
Apr-18-23 Downgrade
Northland Capital
Outperform → Market Perform
$32
Jul-13-22 Initiated
Canaccord Genuity
Buy
$44
Jun-06-22 Resumed
Northland Capital
Outperform
$60
Jun-01-22 Initiated
BMO Capital Markets
Outperform
$50
Feb-09-22 Upgrade
The Benchmark Company
Hold → Buy
$47
Nov-30-21 Resumed
BofA Securities
Buy
$52
Nov-11-21 Initiated
The Benchmark Company
Hold
Nov-11-21 Initiated
Jefferies
Buy
$55
Jul-23-21 Initiated
DA Davidson
Buy
$45
Jun-30-21 Initiated
Robert W. Baird
Outperform
$45
Jun-16-21 Initiated
JP Morgan
Overweight
$41
Apr-01-21 Initiated
BofA Securities
Neutral
$38
Mar-10-21 Initiated
Cowen
Outperform
$50
Mar-09-21 Downgrade
Deutsche Bank
Buy → Hold
$37
Mar-02-21 Initiated
Morgan Stanley
Overweight
$57
Dec-03-20 Initiated
Northland Capital
Outperform
$25
Show Previous Ratings
May-07-24 08:17AM
May-03-24 12:12PM
May-02-24 08:56PM
05:42PM
04:23PM
04:21PM
Loading…
04:21PM
04:11PM
04:05PM
May-01-24 11:00AM
Apr-30-24 07:07AM
Apr-25-24 07:36AM
Apr-17-24 01:00AM
(The Wall Street Journal)
Apr-16-24 08:16PM
Apr-11-24 04:05PM
Apr-08-24 08:30AM
06:00PM
Loading…
Apr-04-24 06:00PM
Apr-03-24 07:00PM
Apr-02-24 11:19AM
Apr-01-24 04:40PM
09:05AM
09:00AM
Mar-27-24 09:30AM
Mar-25-24 06:00PM
Mar-21-24 03:28PM
Mar-19-24 09:00AM
Mar-14-24 05:50PM
Mar-11-24 09:30AM
Mar-08-24 05:50PM
09:00AM
Mar-05-24 06:16AM
07:00AM
Loading…
Mar-04-24 07:00AM
07:00AM
Mar-03-24 12:47PM
Feb-26-24 12:55PM
09:00AM
Feb-23-24 12:10PM
09:30AM
Feb-22-24 04:56PM
04:37PM
04:16PM
04:05PM
Feb-20-24 04:05PM
Feb-16-24 05:50PM
Feb-07-24 05:50PM
Feb-04-24 04:40PM
04:25PM
Feb-02-24 11:40PM
Feb-01-24 04:05PM
Jan-30-24 05:50PM
Jan-22-24 05:50PM
Jan-18-24 06:00PM
Jan-08-24 05:50PM
Jan-02-24 06:00PM
Dec-30-23 09:17AM
Dec-19-23 10:51AM
Dec-04-23 02:56PM
Nov-26-23 06:13AM
Nov-07-23 09:00AM
Nov-03-23 01:33PM
Nov-02-23 05:54PM
04:41PM
04:10PM
04:05PM
Oct-31-23 11:51AM
Oct-25-23 05:50PM
Oct-23-23 04:05PM
09:00AM
Oct-17-23 08:00AM
Oct-13-23 05:50PM
Oct-12-23 09:52PM
04:05PM
Oct-09-23 09:00AM
Oct-06-23 06:00PM
Oct-03-23 12:10PM
Sep-29-23 05:50PM
02:10PM
Sep-27-23 09:00AM
Sep-21-23 05:50PM
Sep-15-23 05:50PM
Sep-14-23 04:05PM
Sep-12-23 09:00AM
Sep-11-23 08:00AM
Sep-08-23 05:50PM
Aug-31-23 04:05PM
Aug-29-23 09:00AM
Aug-16-23 09:00AM
Aug-07-23 09:09AM
Aug-06-23 08:08AM
Aug-04-23 03:36PM
12:01PM
(Thomson Reuters StreetEvents)
Aug-03-23 07:17PM
05:35PM
04:17PM
04:11PM
04:05PM
Aug-02-23 06:15AM
06:00AM
Jul-31-23 12:37PM
Jul-26-23 07:21PM
05:50PM
MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It owns and operates Mountain Pass, an industrial asset, which is the only rare earth mining and processing site of scale in the Western Hemisphere. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Rosenthal Michael Stuart Chief Operating Officer May 31 '23 Buy 20.69 5,000 103,450 126,622 May 31 04:52 PM Rosenthal Michael Stuart Chief Operating Officer May 30 '23 Buy 21.14 6,000 126,840 121,622 May 31 04:52 PM Rosenthal Michael Stuart Chief Operating Officer May 26 '23 Buy 21.63 7,000 151,410 115,622 May 31 04:52 PM JHL Capital Group LLC 10% Owner May 26 '23 Sale 21.70 647,832 14,055,088 0 May 31 04:41 PM Litinsky James H. Chairman and CEO May 26 '23 Sale 21.70 647,832 14,055,088 0 May 31 04:48 PM Rosenthal Michael Stuart Chief Operating Officer May 25 '23 Buy 22.22 5,000 111,100 39,476 May 25 04:31 PM Rosenthal Michael Stuart Chief Operating Officer May 23 '23 Buy 22.03 5,000 110,150 34,476 May 23 06:45 PM Rosenthal Michael Stuart Chief Operating Officer May 22 '23 Buy 21.78 5,000 108,900 29,476 May 22 05:00 PM Rosenthal Michael Stuart Chief Operating Officer May 19 '23 Buy 21.21 10,000 212,100 24,476 May 22 06:08 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite